aa	amino acid
ACT	adoptive cell therapy
ADCC	antibody-dependent cellular cytotoxicity
APC	antigen-presenting cells
APM	antigen-processing machinery
β2m	beta-2 microglobulin
BTK	Bruton tyrosine kinase
CAF	cancer-associated fibroblast
CAR	chimeric antigen receptor
CSF	colony-stimulating factor
CTLA	cytotoxic T lymphocyte antigen
DC	dendritic cells
ECM	extracellular matrix
EMT	epithelial–mesenchymal transition
ER	endoplasmic reticulum
HC	heavy chain
HDAC	histone deacetylase
HLA	human leukocyte antigen
iCP	immune checkpoint
iCPI	immune checkpoint inhibitors
IDO	indoleamine 2,3-dioxygenase
IFN	interferon
IL	interleukin
JAK	janus kinase
KIR	killer immunoglobulin receptors
Lag	lymphocyte-activation gene
MDSC	myeloid-derived suppressor cell
NK	natural killer
NKG2D	Natural Killer group 2 member D
PD1	programmed cell death 1
PD-L1	programmed cell death ligand 1
PI3K	phospho-inositol-3-kinase
PRR	pattern recognition receptor
PTEN	phosphatase and tensin homolog
STAT	signal transducer and activator of transcription
TAA	tumor-associated antigen
TAM	tumor-associated macrophages
TAN	tumor-associated neutrophils
TAP	transporter associated with antigen processing
TCR	T cell receptor
TGF	transforming growth factor
TIGIT	T-cell immunoreceptor with Ig and ITIM domain
TIL	tumor-infiltrating lymphocytes
TIM-3	T-cell immunoglobulin and mucin domain-3
TMB	tumor mutational burden
TME	tumor microenvironment
Treg	regulatory T cells
TSA	tumor-specific antigens
VEGF	vascular endothelial growth factor